Works about ORGANOPLATINUM compounds

Results: 417

Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma.

Published in:

Journal of Neuro-Oncology, 2012, v. 107, n. 1, p. 155, doi. 10.1007/s11060-011-0722-2

By:

Reardon, David;
Desjardins, Annick;
Peters, Katherine;
Gururangan, Sridharan;
Sampson, John;
McLendon, Roger;
Herndon, James;
Bulusu, Anuradha;
Threatt, Stevie;
Friedman, Allan;
Vredenburgh, James;
Friedman, Henry

Publication type:

Article

Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial.

Published in:

2020

By:

Wei, Zhigang;
Yang, Xia;
Ye, Xin;
Feng, Qingliang;
Xu, Yanjun;
Zhang, Licheng;
Sun, Wenqiao;
Dong, Yuting;
Meng, Qi;
Li, Tao;
Wang, Chuntang;
Li, Guangxu;
Zhang, Kaixian;
Li, Peishun;
Bi, Jingwang;
Xue, Guoliang;
Sun, Yahong;
Sheng, Lijun;
Liu, Bin;
Yu, Guohua

Publication type:

journal article

Poly(3,4‐ethylenedioxythiophene) in Dye‐Sensitized Solar Cells: Toward Solid‐State and Platinum‐Free Photovoltaics.

Published in:

Advanced Sustainable Systems, 2021, v. 5, n. 11, p. 1, doi. 10.1002/adsu.202100025

By:

Fagiolari, Lucia;
Varaia, Erica;
Mariotti, Nicole;
Bonomo, Matteo;
Barolo, Claudia;
Bella, Federico

Publication type:

Article

Self-assembly of emissive metallocycles with tetraphenylethylene, BODIPY and terpyridine in one system.

Published in:

Supramolecular Chemistry, 2019, v. 31, n. 8, p. 597, doi. 10.1080/10610278.2019.1659266

By:

Yan, Yu;
Yin, Guang-Qiang;
Khalife, Sandra;
He, Zhan-Hang;
Xu, Chen;
Li, Xiaopeng

Publication type:

Article

Influence on mechanical and rheometric properties through different methods of chemical modification of silica applied to natural rubber compounds.

Published in:

Journal of Elastomers & Plastics, 2021, v. 53, n. 2, p. 165, doi. 10.1177/0095244320915580

By:

Rombaldi, Samuel H;
Pierozan, Nilso José;
Brandalise, Rosmary N

Publication type:

Article

Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast Cancer.

Published in:

Oncologist, 2024, v. 29, n. 5, p. e635, doi. 10.1093/oncolo/oyae025

By:

Wang, Cheng;
Shi, Qiyun;
Zhang, Guozhi;
Wu, Xiujuan;
Yan, Wenting;
Wan, Andi;
Xiong, Siyi;
Yuan, Long;
Tian, Hao;
Ma, Dandan;
Jiang, Jun;
Qi, Xiaowei;
Zhang, Yi

Publication type:

Article

A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with orWithout the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 264, doi. 10.1634/theoncologist.2016-0223

By:

Bendell, Johanna C.;
Hochster, Howard;
Hart, Lowell L.;
Firdaus, Irfan;
Mace, Joseph R.;
McFarlane, Joshua J.;
Kozloff, Mark;
Catenacci, Daniel;
Hsu, Jessie J.;
Hack, Stephen P.;
Shames, David S.;
Phan, See‐Chun;
Koeppen, Hartmut;
Cohn, Allen L.

Publication type:

Article

Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.

Published in:

Oncologist, 2016, v. 21, n. 10, p. 1191, doi. 10.1634/theoncologist.2015-0476

By:

Coriat, Romain;
Walter, Thomas;
Terris, Benoît;
Couvelard, Anne;
Ruszniewski, Philippe

Publication type:

Article

Enhancement of Chiroptical Responses of trans‐Bis[(β‐iminomethyl)naphthoxy]platinum(II) Complexes with Distorted Square Planar Coordination Geometry.

Published in:

ChemistryOpen, 2022, v. 11, n. 4, p. 1, doi. 10.1002/open.202100277

By:

Ikeshita, Masahiro;
Furukawa, Sho;
Ishikawa, Takahiro;
Matsudaira, Kana;
Imai, Yoshitane;
Tsuno, Takashi

Publication type:

Article

Titanium complexes bearing 2,6‐bis(o‐hydroxyalkyl)pyridine ligands in vitro cytotoxicity against triple‐negative breast‐cancer cells.

Published in:

Journal of the Chinese Chemical Society, 2021, v. 68, n. 5, p. 871, doi. 10.1002/jccs.202000393

By:

Chen, I‐Ni;
Ganta, Prasanna Kumar;
Chung, Shou‐Jie;
Chang, Yu‐Lun;
Chang, Heng‐Yi;
Ding, Shangwu;
Chen, Hsuan‐Ying;
Chiu, Chien‐Chih;
Wu, Kuo‐Hui

Publication type:

Article

[Pt(O,O'-acac)(gamma-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway.

Published in:

2008

By:

Muscella, A;
Calabriso, N;
Fanizzi, F P;
De Pascali, S A;
Urso, L;
Ciccarese, A;
Migoni, D;
Marsigliante, S

Publication type:

journal article

Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels.

Published in:

2005

By:

Webster, Richard G;
Brain, Keith L;
Wilson, Richard H;
Grem, Jean L;
Vincent, Angela

Publication type:

journal article

Advances in understanding drug-induced neuropathies.

Published in:

2006

By:

Peltier, Amanda C.;
Russell, James W.

Publication type:

journal article

Synthesis, structure and anticancer studies of Cu (II), Ni (II) and Co (II) complexes based on 2,3-dihydroxybenzaldehyde-2-(2-aminophenyl)benzimidazole Schiff base.

Published in:

Arabian Journal of Chemistry, 2023, v. 16, n. 10, p. N.PAG, doi. 10.1016/j.arabjc.2023.105144

By:

Hou, Min;
Li, Hou Cong;
An, Ning;
Li, Wen Ge;
Tong, Jing

Publication type:

Article

Preparation and Characterization of Chloride-Free Alumina-Supported Platinum Catalysts.

Published in:

Oriental Journal of Chemistry, 2018, v. 34, n. 4, p. 2068, doi. 10.13005/ojc/3404046

By:

ANTI KOLONIAL PRODJOSANTOSO

Publication type:

Article

Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.

Published in:

2010

By:

Bautista, Marnelli A.;
Stevens, W. Tait;
Chien-Shing Chen;
Curtis, Brian R.;
Aster, Richard H.;
Hsueh, Chung-Tsen

Publication type:

Case Study

Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer.

Published in:

2017

By:

Chun-Ming Huang;
Ming-Yii Huang;
Cheng-Jen Ma;
Yung-Sung Yeh;
Hsiang-Lin Tsai;
Ching-Wen Huang;
Chih-Jen Huang;
Jaw-Yuan Wang;
Huang, Chun-Ming;
Huang, Ming-Yii;
Ma, Cheng-Jen;
Yeh, Yung -Sung;
Tsai, Hsiang-Lin;
Huang, Ching-Wen;
Huang, Chih-Jen;
Wang, Jaw-Yuan

Publication type:

journal article

Platinum(IV) complexes of a bulky and exceptionally donating alkyl: 2-adamantyl.

Published in:

Canadian Journal of Chemistry, 2021, v. 99, n. 2, p. 154, doi. 10.1139/cjc-2020-0158

By:

Taullaj, Fioralba;
Fekl, Ulrich;
Lough, Alan J.

Publication type:

Article

Organoplatinum(IV) complexes with functional alkyl groups and their use in supramolecular chemistry<sup>1</sup>.

Published in:

Canadian Journal of Chemistry, 2009, v. 87, n. 7, p. 904, doi. 10.1139/V09-031

By:

Au, Richard H. W.;
Findlay-Shirras, Lisa J.;
Woody, Neil M.;
Jennings, Michael C.;
Puddephatt, Richard J.

Publication type:

Article

Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO.

Published in:

2021

By:

Rossini, Daniele;
Lonardi, Sara;
Antoniotti, Carlotta;
Santini, Daniele;
Tomasello, Gianluca;
Ermacora, Paola;
Germani, Marco Maria;
Bergamo, Francesca;
Ricci, Vincenzo;
Caponnetto, Salvatore;
Moretto, Roberto;
Zaniboni, Alberto;
Pietrantonio, Filippo;
Buonadonna, Angela;
Ritorto, Giuliana;
Masi, Gianluca;
Latiano, Tiziana Pia;
Rapisardi, Stefania;
Falcone, Alfredo;
Cremolini, Chiara

Publication type:

journal article

Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation.

Published in:

2020

By:

Wattenberg, Max M.;
Asch, Daniella;
Yu, Shun;
O'Dwyer, Peter J.;
Domchek, Susan M.;
Nathanson, Katherine L.;
Rosen, Mark A.;
Beatty, Gregory L.;
Siegelman, Evan S.;
Reiss, Kim A.

Publication type:

journal article

Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials.

Published in:

2018

By:

Peeters, Marc;
Price, Timothy;
Taieb, Julien;
Geissler, Michael;
Rivera, Fernando;
Canon, Jean-Luc;
Pentheroudakis, George;
Koukakis, Reija;
Burdon, Peter;
Siena, Salvatore

Publication type:

journal article

Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials.

Published in:

2018

By:

Cremolini, Chiara;
Milione, Massimo;
Marmorino, Federica;
Morano, Federica;
Zucchelli, Gemma;
Mennitto, Alessia;
Prisciandaro, Michele;
Lonardi, Sara;
Pellegrinelli, Alessio;
Rossini, Daniele;
Bergamo, Francesca;
Aprile, Giuseppe;
Urbani, Lucio;
Morelli, Luca;
Schirripa, Marta;
Cardellino, Giovanni Gerardo;
Fassan, Matteo;
Fontanini, Gabriella;
de Braud, Filippo;
Mazzaferro, Vincenzo

Publication type:

journal article

Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.

Published in:

2017

By:

Lièvre, Astrid;
Ouine, Bérèngere;
Canet, Jim;
Cartier, Aurélie;
Amar, Yael;
Cacheux, Wulfran;
Mariani, Odette;
Guimbaud, Rosine;
Selves, Janick;
Lecomte, Thierry;
Guyetant, Serge;
Bieche, Ivan;
Berger, Frédérique;
de Koning, Leanne;
Lièvre, Astrid;
Ouine, Bérèngere;
Cartier, Aurélie;
Berger, Frédérique

Publication type:

journal article

Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.

Published in:

2017

By:

Codony-Servat, Jordi;
Cuatrecasas, Miriam;
Asensio, Elena;
Montironi, Carla;
Martínez-Cardús, Anna;
Marín-Aguilera, Mercedes;
Horndler, Carlos;
Martínez-Balibrea, Eva;
Rubini, Michele;
Jares, Pedro;
Reig, Oscar;
Victoria, Iván;
Gaba, Lydia;
Martín-Richard, Marta;
Alonso, Vicente;
Escudero, Pilar;
Fernández-Martos, Carlos;
Feliu, Jaime;
Méndez, Jose Carlos;
Méndez, Miguel

Publication type:

journal article

Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228).

Published in:

2017

By:

Lévi, Francis;
Karaboué, Abdoulaye;
Saffroy, Raphaël;
Desterke, Christophe;
Boige, Valerie;
Smith, Denis;
Hebbar, Mohamed;
Innominato, Pasquale;
Taieb, Julien;
Carvalho, Carlos;
Guimbaud, Rosine;
Focan, Christian;
Bouchahda, Mohamed;
Adam, René;
Ducreux, Michel;
Milano, Gérard;
Lemoine, Antoinette;
Lévi, Francis;
Karaboué, Abdoulaye;
Saffroy, Raphaël

Publication type:

journal article

Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer.

Published in:

2017

By:

Haas, Michael;
Ormanns, Steffen;
Baechmann, Sibylle;
Remold, Anna;
Kruger, Stephan;
Westphalen, Christoph B;
Siveke, Jens T;
Wenzel, Patrick;
Schlitter, Anna Melissa;
Esposito, Irene;
Quietzsch, Detlef;
Clemens, Michael R;
Kettner, Erika;
Laubender, Ruediger P;
Jung, Andreas;
Kirchner, Thomas;
Boeck, Stefan;
Heinemann, Volker

Publication type:

journal article

Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study.

Published in:

2017

By:

Guren, Tormod Kyrre;
Thomsen, Maria;
Kure, Elin H;
Sorbye, Halfdan;
Glimelius, Bengt;
Pfeiffer, Per;
Österlund, Pia;
Sigurdsson, Fridbjörn;
Lothe, Inger Marie Bowitz;
Dalsgaard, Astrid Marie;
Skovlund, Eva;
Christoffersen, Thoralf;
Tveit, Kjell Magne

Publication type:

journal article

BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer.

Published in:

2017

By:

Pishvaian, Michael J;
Biankin, Andrew V;
Bailey, Peter;
Chang, David K;
Laheru, Daniel;
Wolfgang, Christopher L;
Brody, Jonathan R

Publication type:

journal article

Comment on 'The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome'.

Published in:

2016

By:

Lentschener, Claude;
Nicco, Carole;
Terris, Benoit;
Samama, Charles-Marc;
Coriat, Romain

Publication type:

Letter

Delayed DNA double-strand break repair following platin-based chemotherapy predicts treatment response in head and neck squamous cell carcinoma.

Published in:

2016

By:

Bhide, S A;
Thway, K;
Lee, J;
Wong, K;
Clarke, P;
Newbold, K L;
Nutting, C M;
Harrington, K J

Publication type:

journal article

Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.

Published in:

2016

By:

Bellmunt, Joaquim;
Zhou, Chensheng Willa;
Mullane, Stephanie A;
Werner, Lillian;
Taplin, Mary-Ellen;
Fay, André P;
Choueiri, Toni K;
Orsola, Anna;
Takeda, David Y;
Hahn, William C;
Kim, Jaegil;
Sonpavde, Guru;
Bowden, Michaela;
Fay, André P

Publication type:

journal article

Full-length LGR5-positive cells have chemoresistant characteristics in colorectal cancer.

Published in:

2016

By:

Osawa, Hideki;
Takahashi, Hidekazu;
Nishimura, Junichi;
Ohta, Katsuya;
Haraguchi, Naotsugu;
Hata, Taishi;
Yamamoto, Hirofumi;
Mizushima, Tsunekazu;
Takemasa, Ichiro;
Doki, Yuichiro;
Mori, Masaki

Publication type:

journal article

Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer.

Published in:

2016

By:

Stein, Stacey M;
James, Edward S;
Deng, Yanhong;
Cong, Xiangyu;
Kortmansky, Jeremy S;
Li, Jia;
Staugaard, Carol;
Indukala, Doddamane;
Boustani, Ann Marie;
Patel, Vatsal;
Cha, Charles H;
Salem, Ronald R;
Chang, Bryan;
Hochster, Howard S;
Lacy, Jill

Publication type:

journal article

Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study.

Published in:

2016

By:

Grenader, Tal;
Nash, Stephen;
Adams, Richard;
Kaplan, Richard;
Fisher, David;
Maughan, Tim;
Bridgewater, John

Publication type:

journal article

Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer.

Published in:

2016

By:

Elez, E;
Hendlisz, A;
Delaunoit, T;
Sastre, J;
Cervantes, A;
Varea, R;
Chao, G;
Wallin, J;
Tabernero, J

Publication type:

journal article

Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer.

Published in:

2016

By:

Li, Yilin;
Gong, Jifang;
Zhang, Qiyue;
Lu, Zhihao;
Gao, Jing;
Li, Yanyan;
Cao, Yanshuo;
Shen, Lin

Publication type:

journal article

Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin.

Published in:

2015

By:

Colmegna, B;
Uboldi, S;
Frapolli, R;
Licandro, S A;
Panini, N;
Galmarini, C M;
Badri, Nadia;
Spanswick, V J;
Bingham, J P;
Kiakos, Konstantinos;
Erba, E;
Hartley, J A;
D'Incalci, M

Publication type:

journal article

Pathological responses after angiogenesis or EGFR inhibitors in metastatic colorectal cancer depend on the chemotherapy backbone.

Published in:

2015

By:

Carrasco, J;
Gizzi, M;
Pairet, G;
Lannoy, V;
Lefesvre, P;
Gigot, J-F;
Hubert, C;
Jouret-Mourin, A;
Humblet, Y;
Canon, J-L;
Sempoux, C;
Chapaux, X;
Danse, E;
Tinton, N;
Navez, B;
Van den Eynde, M

Publication type:

journal article

Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting.

Published in:

2015

By:

Lambrechts, Diether;
Thienpont, Bernard;
Thuillier, Vincent;
Sagaert, Xavier;
Moisse, Matthieu;
Peuteman, Gilian;
Pericay, Carles;
Folprecht, Gunnar;
Zalcberg, John;
Zilocchi, Chiara;
Margherini, Emmanuelle;
Chiron, Marielle;
Van Cutsem, Eric

Publication type:

journal article

Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancer.

Published in:

2015

By:

Stein, Alexander;
Atanackovic, Djordje;
Hildebrandt, Bert;
Stübs, Patrick;
Brugger, Wolfram;
Hapke, Gunnar;
Steffens, Claus-Christoph;
Illerhaus, Gerald;
Bluemner, Ernst;
Stöhlmacher, Jan;
Bokemeyer, Carsten;
Stübs, Patrick;
Stöhlmacher, Jan

Publication type:

journal article

Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction.

Published in:

2011

By:

Wainberg, Z. A.;
Lin, L.-S.;
DiCarlo, B.;
Dao, K. M.;
Patel, R.;
Park, D. J.;
Wang, H.-J.;
Elashoff, R.;
Ryba, N.;
Hecht, J. R.

Publication type:

journal article

DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6.

Published in:

2011

By:

O'Connor, J. P. B.;
Rose, C. J.;
Jackson, A.;
Watson, Y.;
Cheung, S.;
Maders, F.;
Whitcher, B. J.;
Roberts, C.;
Buonaccorsi, G. A.;
Thompson, G.;
Clamp, A. R.;
Jayson, G. C.;
Parker, G. J. M.

Publication type:

journal article

A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours.

Published in:

2011

By:

Plummer, R.;
Wilson, R. H.;
Calvert, H.;
Boddy, A. V.;
Griffin, M.;
Sludden, J.;
Tilby, M. J.;
Eatock, M.;
Pearson, D. G.;
Ottley, C. J.;
Matsumura, Y.;
Kataoka, K.;
Nishiya, T.

Publication type:

journal article

Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity.

Published in:

2011

By:

Kim, K.-p.;
Jang, G.;
Hong, Y. S.;
Lim, H.-S.;
Bae, K.-s.;
Kim, H.-S.;
Lee, S. S.;
Shin, J.-G.;
Lee, J.-L.;
Ryu, M.-H.;
Chang, H.-M.;
Kang, Y.-K.;
Kim, T. W.

Publication type:

journal article

Phase II study of nedaplatin and irinotecan with concurrent thoracic radiotherapy in patients with locally advanced non-small-cell lung cancer.

Published in:

2010

By:

Oshita, F.;
Ohe, M.;
Honda, T.;
Murakami, S.;
Kondo, T.;
Saito, H.;
Noda, K.;
Yamashita, K.;
Nakayama, Y.;
Yamada, K.

Publication type:

journal article

Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial.

Published in:

2010

By:

Garufi, C.;
Torsello, A.;
Tumolo, S.;
Ettorre, G. M.;
Zeuli, M.;
Campanella, C.;
Vennarecci, G.;
Mottolese, M.;
Sperduti, I.;
Cognetti, F.

Publication type:

journal article

Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer.

Published in:

2010

By:

Conroy, T.;
Yataghène, Y.;
Etienne, P. L.;
Michel, P.;
Senellart, H.;
Raoul, J. L.;
Mineur, L.;
Rives, M.;
Mirabel, X.;
Lamezec, B.;
Rio, E.;
Le Prisé, E.;
Peiffert, D.;
Adenis, A.;
Yataghène, Y;
Le Prisé, E

Publication type:

journal article

Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol.

Published in:

2018

By:

Namikawa, Tsutomu;
Maeda, Hiromichi;
Kitagawa, Hiroyuki;
Oba, Koji;
Tsuji, Akihito;
Yoshikawa, Takaki;
Kobayashi, Michiya;
Hanazaki, Kazuhiro

Publication type:

journal article

The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP.

Published in:

2018

By:

Streckmann, Fiona;
Balke, Maryam;
Lehmann, Helmar C.;
Rustler, Vanessa;
Koliamitra, Christina;
Elter, Thomas;
Hallek, Michael;
Leitzmann, Michael;
Steinmetz, Tilman;
Heinen, Petra;
Baumann, Freerk T.;
Bloch, Wilhelm

Publication type:

journal article